CRISPR Medicine News, 31 July 2020 | Your Missing Links - CRISPR Medicine

Your missing links are here

Top picks




  • The explosion of new coronavirus tests that could help to end the pandemic. Research groups around the world are devising diagnostic tests that go beyond the gold standard PCR, and churn out millions of tests a week. Some use CRISPR gene-editing to home in on genetic snippets of SARS-CoV-2.
  • Promising results in BioRxiv preprint. Rapid, sensitive and specific SARS coronavirus-2 detection: a multi-center comparison between standard qRT-PCR and CRISPR-based DETECTR.
  • Anthony Fauci interview by Ed Yong on The Atlantic.
  • George Church and other scientist are sniffing home-made COVID19 vaccines.

Vision and opinion


Heh, huh, wow

  • The making of a scientist. Nobel Laureate Mario Capecchi’s story is a story of hope for those who struggle early in life. »… at age 4½, I set off on my own. I headed south, sometimes living in the streets, sometimes joining gangs of other homeless children, sometimes living in orphanages, and most of the time being hungry...« Mario Capecchi, born 1937, spent years on the streets in Italy and nearly died of malnutrition in a hospital. In 2007, he was awarded the Medicine Prize »for their discoveries of principles for introducing specific gene modifications in mice by the use of embryonic stem cells«.
  • Say moo to Cosmo the CRISPR calf, and the many CRISPR challenges the scientists ran into. UCDavis also has the story.
  • Lab-grown sperm could let infertile men have gene-edited children.

Don't miss: Tonight your offer ends for 50% discount for 12-month subscriptions on CRISPR Medicine News.
You may take advantage of this discount using the promo code: CMN2020 when you follow this link:

The deadline for the 50% offer is 1st August 2020.

Remember, all students have free access to all content on CRISPR Medicine News. Our newsletter will also stay free, and new articles will be open to read for the first three days.

Thank You for now.

And if you have questions or suggestions, you can directly reach us at We love hearing from readers!

(c; Rasmus


You can follow the blog on Twitter and LinkedIn. If someone forwarded this email to you, you can sign up yourself here.